InsidersTradesSigma
Browse the full directors' dealings record of Newbury Pharmaceuticals AB, a listed equity based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Newbury Pharmaceuticals AB has logged 2 reports. Market capitalisation: €42.9m. The latest transaction was disclosed on 18 November 2025 — Purchase. Among the most active insiders: Alsakali Equity AB. Every trade is accessible without an account.
FY ended August 2025 · cache
0 of 0 declarations